BPC-157: Mechanism, Research & Sourcing

Mechanism of action

BPC-157 has been studied for its effects on angiogenesis (formation of new blood vessels), nitric oxide signaling, growth-hormone receptor expression, and stabilization of the VEGFR2 pathway. Pre-clinical models suggest these mechanisms contribute to accelerated tissue repair in tendons, ligaments, muscle, and intestinal lining.

Key research areas

• Tendon and ligament repair — multiple rodent models demonstrating improved healing kinetics.
• Gut and gastrointestinal research — protective effects against NSAID-induced lesions.
• Muscle injury models — accelerated regeneration after crush and tear injuries.
• Neuroprotective research — early-stage studies in nerve injury and TBI models.

Dosing models in research

Published animal studies typically use 10 mcg/kg/day in rodents. Researchers calculating human-equivalent doses for protocol design commonly land in the 200–500 mcg/day range, though dosing is highly protocol-specific and BPC-157 is not approved for human therapeutic use.

Reconstitution

BPC-157 ships as a lyophilized powder. Reconstitute with bacteriostatic water. A common ratio is 5mg + 2mL bac water = 2.5mg/mL (2,500 mcg/mL). Refrigerate after mixing and use within 28 days. Full reconstitution guide →

BPC-157 + TB-500: the "Wolverine" stack

BPC-157 is frequently paired with TB-500 (thymosin beta-4 fragment) in recovery research. The combination is studied for complementary mechanisms — BPC-157 driving angiogenesis and VEGFR2 stabilization, TB-500 driving actin sequestration and cellular migration. View the Wolverine stack →

Buy BPC-157 with CoA

HerAmino ships BPC-157 with third-party HPLC and mass-spec verification at ≥ 99% purity. A Certificate of Analysis is included on every order. Shop research peptides →

For in-vitro research use only. Not a drug or supplement. Not evaluated by the FDA.